• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Myasthenia Gravis (MG) 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for MG trials.

DOWNLOAD BROCHURE

Effective solutions for advancing Myasthenia Gravis research

Myasthenia gravis is a rare chronic disease that weakens and fatigues an individual's skeletal muscles. Symptoms fluctuate throughout the day, making it difficult to assess patients consistently and accurately. Signant SmartSignals digital solutions help generate reliable evidence for the development of treatments and therapies.

MG-1

Why Signant Health

  • Collect Primary Endpoints
  • Protect Endpoint Data Quality
  • Prevent Rating Inconsistencies
  • Gain Expert Guidance
  • Monitor Patients Remotely
  • Manage Various Consents
  • Collect Primary Endpoints

    Collect Primary Endpoints

    Featuring completion windows and timestamps, Signant SmartSignals eCOA solution guarantees data is collected at the times specified by the protocol and will demonstrate the data’s integrity. The comprehensive library of questionnaires can help you capture all clinically relevant factors needed. 

  • Protect Endpoint Data Quality

    Protect Endpoint Data Quality

    Signant’s PureSignal Analytics safeguards COA data from inconsistent assessments and administration or scoring errors to help optimize signal detection. The solution combines proprietary algorithms with deep expertise of our in-house clinicians to deliver targeted interventions where needed. 
     

  • Prevent Rating Inconsistencies

    Prevent Rating Inconsistencies

    Our Rater Training & Qualification solution includes a fully customizable curriculum that standardizes scale knowledge and assessment techniques among raters. Providing targeted trainings and refreshers throughout study, the comprehensive program reduces variability.
     
     

  • Gain Expert Guidance

    Gain Expert Guidance

    From designing protocols and enrolling patients to mitigating data issues, Signant’s in-house experts will help you navigate common myasthenia gravis challenges from the study's start to closeout.
     

  • Monitor Patients Remotely

    Monitor Patients Remotely

    Replace the clinic visits that do not require in-person assessments with a convenient video consultation via our Telemedicine solution. You'll not only be able to regularly check in with the immunocompromised patients, but you'll also be able to thoroughly review lab tests and medical images with them.
     
     

  • Manage Various Consents

    Manage Various Consents

    Signant’s eConsent ensures each consent and reconsent is completed with the correct IRB- or EC-approved form. Available in tiered options to fit any study, eConsent uses engaging multimedia to educate patients for a truly informed signature.

Comprehensive Myasthenia Gravis experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Myasthenia Gravis trial resources
SOLUTION BROCHURE

Myasthenia Gravis Trial Solutions Overview


GET INSIGHTS
VIDEO

Myasthenia Gravis Trial Solutions


WATCH [2 MIN]
BLOG

Myasthenia Gravis: Reducing Outcome Measures Variability in Trials

 
READ BLOG

eClinical Solutions for Myasthenia Gravis trials

Accelerate your Myasthenia Gravis trial success

Discover how Signant's specialized solutions can address unique challenges in your current or upcoming Myasthenia Gravis research.

DISCUSS PROTOCOL